A trust reaping the rewards of the healthcare revival
After a long period in the doldrums, the biotechnology sector is staging a comeback. A more benign interest…
Private Investor’s Diary: Three strategies that are paying off
If February marked the divergence of global equities from the US, March saw geopolitical events take centre stage.…
The market rallies investors are missing
The rise of the tracker fund has meant many investors are betting that today’s winners, or a market’s…